PMID: 24517344

Raju SV, Tate JH, Peacock SK, Fang P, Oster RA, Dransfield MT, Rowe SM
Impact of heterozygote CFTR mutations in COPD patients with chronic bronchitis.
Respir Res. 2014 Feb 11;15:18. doi: 10.1186/1465-9921-15-18., [PubMed]
Sentences
No. Mutations Sentence Comment
81 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 24517344:81:407
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 24517344:81:259
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 24517344:81:314
status: NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 24517344:81:413
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 24517344:81:349
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 24517344:81:288
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 24517344:81:320
status: NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Gly314Glu
X
ABCC7 p.Gly314Glu 24517344:81:369
status: NEW
view ABCC7 p.Gly314Glu details
ABCC7 p.Arg347His
X
ABCC7 p.Arg347His 24517344:81:429
status: NEW
view ABCC7 p.Arg347His details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 24517344:81:435
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 24517344:81:375
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 24517344:81:472
status: NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Ser1251Asn
X
ABCC7 p.Ser1251Asn 24517344:81:543
status: NEW
view ABCC7 p.Ser1251Asn details
ABCC7 p.Pro205Ser
X
ABCC7 p.Pro205Ser 24517344:81:781
status: NEW
view ABCC7 p.Pro205Ser details
ABCC7 p.Leu206Trp
X
ABCC7 p.Leu206Trp 24517344:81:827
status: NEW
view ABCC7 p.Leu206Trp details
ABCC7 p.Gln493*
X
ABCC7 p.Gln493* 24517344:81:655
status: NEW
view ABCC7 p.Gln493* details
ABCC7 p.Val520Phe
X
ABCC7 p.Val520Phe 24517344:81:517
status: NEW
view ABCC7 p.Val520Phe details
ABCC7 p.Ser549Arg
X
ABCC7 p.Ser549Arg 24517344:81:758
status: NEW
view ABCC7 p.Ser549Arg details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 24517344:81:283
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 24517344:81:729
status: NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Tyr122*
X
ABCC7 p.Tyr122* 24517344:81:308
status: NEW
view ABCC7 p.Tyr122* details
ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 24517344:81:381
status: NEW
view ABCC7 p.Arg560Thr details
ABCC7 p.Arg1158*
X
ABCC7 p.Arg1158* 24517344:81:640
status: NEW
view ABCC7 p.Arg1158* details
ABCC7 p.Met1101Lys
X
ABCC7 p.Met1101Lys 24517344:81:936
status: NEW
view ABCC7 p.Met1101Lys details
ABCC7 p.Arg1066Cys
X
ABCC7 p.Arg1066Cys 24517344:81:503
status: NEW
view ABCC7 p.Arg1066Cys details
ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 24517344:81:842
status: NEW
view ABCC7 p.Tyr1092* details
ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 24517344:81:881
status: NEW
view ABCC7 p.Tyr1092* details
ABCC7 p.His199Tyr
X
ABCC7 p.His199Tyr 24517344:81:744
status: NEW
view ABCC7 p.His199Tyr details
ABCC7 p.Ser1255*
X
ABCC7 p.Ser1255* 24517344:81:550
status: NEW
view ABCC7 p.Ser1255* details
ABCC7 p.Gln552*
X
ABCC7 p.Gln552* 24517344:81:723
status: NEW
view ABCC7 p.Gln552* details
ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 24517344:81:896
status: NEW
view ABCC7 p.Asp1152His details
ABCC7 p.Lys710*
X
ABCC7 p.Lys710* 24517344:81:455
status: NEW
view ABCC7 p.Lys710* details
ABCC7 p.Phe508Cys
X
ABCC7 p.Phe508Cys 24517344:81:866
status: NEW
view ABCC7 p.Phe508Cys details
ABCC7 p.Arg764*
X
ABCC7 p.Arg764* 24517344:81:634
status: NEW
view ABCC7 p.Arg764* details
ABCC7 p.Arg117Cys
X
ABCC7 p.Arg117Cys 24517344:81:277
status: NEW
view ABCC7 p.Arg117Cys details
ABCC7 p.Trp1089*
X
ABCC7 p.Trp1089* 24517344:81:510
status: NEW
view ABCC7 p.Trp1089* details
ABCC7 p.Ile506Thr
X
ABCC7 p.Ile506Thr 24517344:81:684
status: NEW
view ABCC7 p.Ile506Thr details
ABCC7 p.Gly480Cys
X
ABCC7 p.Gly480Cys 24517344:81:497
status: NEW
view ABCC7 p.Gly480Cys details
ABCC7 p.Ser1196*
X
ABCC7 p.Ser1196* 24517344:81:529
status: NEW
view ABCC7 p.Ser1196* details
ABCC7 p.Glu60*
X
ABCC7 p.Glu60* 24517344:81:492
status: NEW
view ABCC7 p.Glu60* details
ABCC7 p.Gly178Arg
X
ABCC7 p.Gly178Arg 24517344:81:335
status: NEW
view ABCC7 p.Gly178Arg details
ABCC7 p.Gln1238*
X
ABCC7 p.Gln1238* 24517344:81:536
status: NEW
view ABCC7 p.Gln1238* details
ABCC7 p.Gly330*
X
ABCC7 p.Gly330* 24517344:81:401
status: NEW
view ABCC7 p.Gly330* details
ABCC7 p.Ala559Thr
X
ABCC7 p.Ala559Thr 24517344:81:523
status: NEW
view ABCC7 p.Ala559Thr details
ABCC7 p.Gln98Arg
X
ABCC7 p.Gln98Arg 24517344:81:718
status: NEW
view ABCC7 p.Gln98Arg details
ABCC7 p.Arg709*
X
ABCC7 p.Arg709* 24517344:81:628
status: NEW
view ABCC7 p.Arg709* details
ABCC7 p.Trp1098*
X
ABCC7 p.Trp1098* 24517344:81:953
status: NEW
view ABCC7 p.Trp1098* details
ABCC7 p.Val520Ile
X
ABCC7 p.Val520Ile 24517344:81:903
status: NEW
view ABCC7 p.Val520Ile details
As expected based on genotype-phenotype correlations in the disease [33], HBE cells derived from a F508del CFTR heterozygote had slightly lower CFTR activity at baseline than wild type monolayers as measured by Table 1 List of CFTR mutations analyzed F508del R117H 1717-1G > A R117C G85E R334W 1898 + 1G > A Y122X A455E R347P 2184delA G178R I507del R553X 2789 + 5G > A G314E G542X R560T 3120 + 1G > A G330X G551D W1282X 3659delC R347H N1303K 621 + 1G > T K710X 406-1G > A R1162X 711 + 1G > T E60X G480C R1066C W1089X V520F A559T S1196X Q1238X S1251N S1255X 663delT 935delA 1161delC 1288insTA 2184insA 2307insA 2711delT 2869insG R709X R764X R1158X 574delA Q493X 1898 + 5G > T 3905insT I506T 3849 + 10kbC > T 712-1G > T Q98R Q552X S549N 1078delT H199Y 444delA S549R (T > G) 2143delT P205S 2043delG 1811 + 1.6kbA > G 3272-26A > G L206W 3791delC Y1092X (C > G) 3199del6 F508C 2108delA Y1092X (C > A) D1152H V520I 3667del4 394delTT 3876delA M1101K 1677delTA W1098X (TGA) 1812-1G > A 4016insT 1609delCA 3171delC response to forskolin stimulation (49.3 &#b1; 11.5 bc;A/cm2 in CFTR (+/+) vs. 40.5 &#b1; 5.3 bc;A/cm2 in CFTR (+/-), although this was not statistically significant (Figure 1A,B). Login to comment
135 ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 24517344:135:72
status: NEW
view ABCC7 p.Arg75Gln details
Similarly, we did not observe any increase in the incidence of M470V or R75Q as reported earlier in COPD patients from Serbia [22,23]. Login to comment
210 ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 24517344:210:156
status: NEW
view ABCC7 p.Arg75Gln details
Divac A, Nikolic A, Mitic-Milikic M, Nagorni-Obradovic L, Petrovic-Stanojevic N, Dopudja-Pantic V, Nadaskic R, Savic A, Radojkovic D: High frequency of the R75Q CFTR variation in patients with chronic obstructive pulmonary disease. Login to comment